FAS and obesity due to melanocortin 4 receptor deficiency: Overall, our results show for the first time that AMPK-mediated FAS/HSL pathway was implicated in the beneficial effect of Nuci in reducing lipid accumulation, providing experimental evidence for clinical application of Nuci in treating obesity and related metabolic dysfunctions.